Vortrag am FONDS professionell KONGRESSInvesco Markets p.Nasdaq Biotech UE A
| MVD-Fonds Rating | EDA |
|---|---|
  | - |
ISIN: IE00BQ70R696 | WKN: A12CCJ
KAG: Invesco IM
NAV: 44,73 USD am 02.02.2023
Portfolio
Watchlist
KursalarmChart
Kennzahlen Invesco Markets p.Nasdaq Biotech UE A
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +4,24% | +12,89% | +4,68% | +20,68% | +24,84% | - | +45,13% |
| Volatilität | +15,26% | +24,53% | +27,63% | +28,14% | +25,79% | - | +25,47% |
| Sharpe Ratio | +4,15 | +1,01 | +0,08 | +0,14 | +0,08 | - | +0,08 |
| Bester Monat | - | +8,88% | +8,88% | +14,98% | +14,98% | - | +14,98% |
| Schl. Monat | - | -2,97% | -9,76% | -11,90% | -14,63% | - | -21,04% |
| Max. Verlust | -2,30% | -15,09% | -21,88% | -38,26% | -38,26% | - | -39,40% |
Monatsperformance Invesco Markets p.Nasdaq Biotech UE A
| 2023 | 2022 | 2021 | 2020 | 2019 | |
| Januar | +3,47% | -11,90% | +6,22% | -5,63% | +13,36% |
| Februar | -0,18% | -3,98% | -2,31% | +0,33% | +2,69% |
| März | - | +4,31% | -4,25% | -5,32% | -0,84% |
| April | - | -9,76% | +2,94% | +14,98% | -4,85% |
| Mai | - | -1,20% | -1,96% | +8,48% | -6,06% |
| Juni | - | +1,09% | +8,04% | +1,64% | +9,26% |
| Juli | - | +4,08% | -0,23% | -1,73% | -3,11% |
| August | - | -0,99% | +4,13% | +0,92% | -2,61% |
| September | - | -2,39% | -4,87% | -0,10% | -3,26% |
| Oktober | - | +8,88% | -1,92% | -3,76% | +7,70% |
| November | - | +5,92% | -3,91% | +11,16% | +11,46% |
| Dezember | - | -2,97% | -1,26% | +4,54% | +0,88% |
| Gesamt | +3,28% | -10,48% | -0,36% | +25,92% | +24,62% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (Invesco Markets plc-Nasdaq Biotech UCITS ETF) oder suchen Sie weitere Top-Fonds zum Thema Aktien (ETF Aktien) USA in USD:
Fonds vergleichenWeitere ähnliche Fonds